These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers at a Tertiary Academic Hospital in New York City. Mansour M; Leven E; Muellers K; Stone K; Mendu DR; Wajnberg A J Gen Intern Med; 2020 Aug; 35(8):2485-2486. PubMed ID: 32495088 [No Abstract] [Full Text] [Related]
3. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study. Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107 [TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020. Feehan AK; Fort D; Garcia-Diaz J; Price-Haywood EG; Velasco C; Sapp E; Pevey D; Seoane L Emerg Infect Dis; 2020 Nov; 26(11):2766-2769. PubMed ID: 32731911 [TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of SARS-Cov-2 in 646 professionals at the Rothschild Foundation Hospital (ProSeCoV study). Mesnil M; Joubel K; Yavchitz A; Miklaszewski N; Devys JM Anaesth Crit Care Pain Med; 2020 Oct; 39(5):595-596. PubMed ID: 32861816 [No Abstract] [Full Text] [Related]
6. Prevalence of Severe Acute Respiratory Syndrome Coronavirus-2-specific Antibodies in German Blood Donors during the COVID-19 Pandemic. Runkel S; Kowalzik F; Gehring S; Winter J; Grandt CL; Marron M; Seifert-Hitzler S; Hitzler WE Clin Lab; 2020 Oct; 66(10):. PubMed ID: 33073955 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic. Stavert R; Meydani-Korb A; de Leon D; Osgood R; Blau J; Luu T J Am Acad Dermatol; 2020 Dec; 83(6):1753-1755. PubMed ID: 32822790 [No Abstract] [Full Text] [Related]
8. Notes from the Field: Seroprevalence Estimates of SARS-CoV-2 Infection in Convenience Sample - Oregon, May 11-June 15, 2020. Sutton M; Cieslak P; Linder M MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(32):1100-1101. PubMed ID: 32790658 [No Abstract] [Full Text] [Related]
9. Severe Acute Respiratory Syndrome Coronavirus 2 among Asymptomatic Workers Screened for Work Resumption, China. Han X; Wei X; Alwalid O; Cao Y; Li Y; Wang L; Shi H Emerg Infect Dis; 2020 Sep; 26(9):2265-7. PubMed ID: 32553070 [TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2-Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence. den Hartog G; Schepp RM; Kuijer M; GeurtsvanKessel C; van Beek J; Rots N; Koopmans MPG; van der Klis FRM; van Binnendijk RS J Infect Dis; 2020 Oct; 222(9):1452-1461. PubMed ID: 32766833 [TBL] [Abstract][Full Text] [Related]
11. Reopening Society and the Need for Real-Time Assessment of COVID-19 at the Community Level. Angulo FJ; Finelli L; Swerdlow DL JAMA; 2020 Jun; 323(22):2247-2248. PubMed ID: 32412582 [No Abstract] [Full Text] [Related]
12. Covid-19 antibody tests: a briefing. Baraniuk C BMJ; 2020 Jun; 369():m2284. PubMed ID: 32580937 [No Abstract] [Full Text] [Related]
13. High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies. Boukli N; Le Mene M; Schnuriger A; Cuervo NS; Laroche C; Morand-Joubert L; Gozlan J J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32848041 [No Abstract] [Full Text] [Related]
14. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip. Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461 [TBL] [Abstract][Full Text] [Related]
15. A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies. Goetz L; Yang J; Greene W; Zhu Y J Appl Lab Med; 2020 Nov; 5(6):1401-1405. PubMed ID: 32745181 [No Abstract] [Full Text] [Related]
16. Frequency of COVID-19 IgG Antibodies among Special Police Squad Lahore, Pakistan. Chughtai OR; Batool H; Khan MD; Chughtai AS J Coll Physicians Surg Pak; 2020 Jul; 30(7):735-739. PubMed ID: 32811605 [TBL] [Abstract][Full Text] [Related]
17. Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives. Infantino M; Damiani A; Gobbi FL; Grossi V; Lari B; Macchia D; Casprini P; Veneziani F; Villalta D; Bizzaro N; Cappelletti P; Fabris M; Quartuccio L; Benucci M; Manfredi M Isr Med Assoc J; 2020 Apr; 22(4):203-210. PubMed ID: 32286019 [No Abstract] [Full Text] [Related]
18. Evaluation of an Electrochemiluminescent SARS-CoV-2 Antibody Assay. Lau CS; Hoo SP; Yew SF; Ong SK; Lum LT; Heng PY; Tan JG; Wong MS; Aw TC J Appl Lab Med; 2020 Nov; 5(6):1313-1323. PubMed ID: 32717060 [TBL] [Abstract][Full Text] [Related]
19. Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG. Sapkal G; Shete-Aich A; Jain R; Yadav PD; Sarkale P; Lakra R; Baradkar S; Deshpande GR; Mali D; Tilekar BN; Majumdar T; Kaushal H; Gurav Y; Gupta N; Mohandas S; Deshpande K; Kaduskar O; Salve M; Patil S; Gaikwad S; Sugunan AP; Ashok M; Giri S; Shastri J; Abraham P; Gangakhedkar RR; Indian J Med Res; 2020 May; 151(5):444-449. PubMed ID: 32611915 [TBL] [Abstract][Full Text] [Related]